BankPlus Trust Department’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
BankPlus Trust Department's BMY Position: Q2 2026 in Review
BankPlus Trust Department increased its Bristol-Myers Squibb (BMY) stake by 2.6% in Q2 2026, buying an estimated $48.2K and bringing the position to 32,563 shares worth $1.88M. The position accounts for 0.44% of the portfolio, ranked #54.
BankPlus Trust Department first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.95M in Q4 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- BankPlus Trust Department held 32,563 shares of Bristol-Myers Squibb worth $1.88M as of Q2 2026.
- BankPlus Trust Department bought 839 Bristol-Myers Squibb shares in Q2 2026, an estimated $48.2K.
- Bristol-Myers Squibb made up 0.44% of BankPlus Trust Department's portfolio in Q2 2026, its #54 holding.
- BankPlus Trust Department first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
- BankPlus Trust Department's Bristol-Myers Squibb position peaked at $1.95M in Q4 2025.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on BankPlus Trust Department's 13F filing for Q2 2026, filed 28 Jul 2026.